|
RIGL Rigel Pharmaceuticals Inc 1034842 |
| Balance Sheet |
|
Current Assets
|
$234,027,000.00 |
|
Assets
|
$504,608,000.00 |
|
Current Liabilities
|
$89,492,000.00 |
|
Liabilities
|
$104,711,000.00 |
|
Equity
|
$399,897,000.00 |
|
Shares Out
|
18310934.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$2,725,000.00 |
|
Investing Cash Flow
|
$-7,975,000.00 |
| Market Analysis |
Market Cap
|
$696,914,148.04 |
|
Price
|
$36.67 |
|
BVPS
|
21.84 |
|
PB
|
1.74 |
|
EPS
|
0.47 |
|
PE
|
2.10 |
|
PS
|
3.01 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:28 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:24 |
|
| Apr |
May |
Jun |
| 2026-03-03 |
13.54 |
|
|
2026-05-05 |
0.44 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
3.28 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
1.46 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RIGL documents filed with the SEC.
RIGL Filings
Clear
